Harmony Biosciences Holdings, Inc. - Common Stock (HRMY)
CUSIP: 413197104
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,644,670
- Total 13F shares
- 49,527,453
- Share change
- -2,499,701
- Total reported value
- $1,623,105,557
- Put/Call ratio
- 37%
- Price per share
- $32.77
- Number of holders
- 203
- Value change
- -$85,461,798
- Number of buys
- 114
- Number of sells
- 93
Quarterly Holders Quick Answers
What is CUSIP 413197104?
CUSIP 413197104 identifies HRMY - Harmony Biosciences Holdings, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 413197104:
Top shareholders of HRMY - Harmony Biosciences Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Valor Management LLC |
13F
|
Company |
19%
|
11,218,033
|
$394,762,581 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
10%
|
5,750,478
|
$202,359,321 | — | 30 Jun 2023 | |
| FMR LLC |
13F
|
Company |
9.5%
|
5,470,247
|
$192,497,996 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.2%
|
3,595,857
|
$126,538,208 | — | 30 Jun 2023 | |
| Vivo Capital, LLC |
13F
|
Company |
4.5%
|
2,606,247
|
$91,713,832 | — | 30 Jun 2023 | |
| Andreas Wicki |
3/4/5
|
Director |
—
class O/S missing
|
2,147,943
|
$71,655,378 | — | 12 Dec 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.1%
|
1,200,000
|
$42,228,000 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
2%
|
1,140,934
|
$40,149,467 | — | 30 Jun 2023 | |
| venBio Partners LLC |
13F
|
Company |
1.8%
|
1,035,396
|
$36,435,585 | — | 30 Jun 2023 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.6%
|
901,528
|
$31,725,000 | — | 30 Jun 2023 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.5%
|
891,370
|
$31,367,310 | — | 30 Jun 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.4%
|
800,860
|
$28,182,263 | — | 30 Jun 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.3%
|
732,551
|
$25,778,673 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
730,024
|
$25,689,545 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
661,306
|
$23,271,369 | — | 30 Jun 2023 | |
| Aberdeen Group plc |
13F
|
Company |
1.1%
|
644,248
|
$22,671,087 | — | 30 Jun 2023 | |
| NEUMEIER POMA INVESTMENT COUNSEL LLC |
13F
|
Company |
1.1%
|
636,240
|
$22,389,286 | — | 30 Jun 2023 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.99%
|
570,500
|
$20,070,190 | — | 30 Jun 2023 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.88%
|
507,334
|
$17,853,083 | — | 30 Jun 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.85%
|
488,400
|
$17,186,796 | — | 30 Jun 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.84%
|
485,912
|
$17,099,243 | — | 30 Jun 2023 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.82%
|
473,040
|
$16,646,272 | — | 30 Jun 2023 | |
| ASHFORD CAPITAL MANAGEMENT INC |
13F
|
Company |
0.78%
|
449,038
|
$15,801,647 | — | 30 Jun 2023 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.76%
|
436,705
|
$15,367,649 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.71%
|
410,400
|
$14,442,000 | — | 30 Jun 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.7%
|
402,800
|
$14,174,532 | — | 30 Jun 2023 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.64%
|
368,665
|
$12,973,321 | — | 30 Jun 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.62%
|
358,093
|
$12,601,293 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.58%
|
332,284
|
$11,693,074 | — | 30 Jun 2023 | |
| Man Group plc |
13F
|
Company |
0.55%
|
318,899
|
$11,222,055 | — | 30 Jun 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.55%
|
317,003
|
$11,155,336 | — | 30 Jun 2023 | |
| GREAT LAKES ADVISORS, LLC |
13F
|
Company |
0.54%
|
313,047
|
$11,016,129 | — | 30 Jun 2023 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.54%
|
312,957
|
$11,013,000 | — | 30 Jun 2023 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.52%
|
300,000
|
$10,557,000 | — | 30 Jun 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.5%
|
286,024
|
$10,065,185 | — | 30 Jun 2023 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.47%
|
271,200
|
$9,543,528 | — | 30 Jun 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.44%
|
253,857
|
$8,933,227 | — | 30 Jun 2023 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.43%
|
250,122
|
$8,801,793 | — | 30 Jun 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.43%
|
248,175
|
$8,733,278 | — | 30 Jun 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.42%
|
240,461
|
$8,461,822 | — | 30 Jun 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.42%
|
240,216
|
$8,453,201 | — | 30 Jun 2023 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.38%
|
219,579
|
$7,726,985 | — | 30 Jun 2023 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.36%
|
210,000
|
$7,389,900 | — | 30 Jun 2023 | |
| Tributary Capital Management, LLC |
13F
|
Company |
0.36%
|
206,218
|
$7,256,811 | — | 30 Jun 2023 | |
| Walleye Capital LLC |
13F
|
Company |
0.34%
|
196,200
|
$6,904,278 | — | 30 Jun 2023 | |
| NORGES BANK |
13F
|
Company |
0.33%
|
190,328
|
$6,697,642 | — | 30 Jun 2023 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.33%
|
189,755
|
$6,677,478 | — | 30 Jun 2023 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.32%
|
183,490
|
$6,457,013 | — | 30 Jun 2023 | |
| Altium Capital Management LLC |
13F
|
Company |
0.26%
|
149,889
|
$5,274,594 | — | 30 Jun 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.26%
|
147,429
|
$5,188,027 | — | 30 Jun 2023 |
Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q3 2023
As of 30 Sep 2023,
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) was held by
203 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,527,453 shares.
The largest 10 holders included
Valor Management LLC, BlackRock Inc., FMR LLC, VANGUARD GROUP INC, Vivo Capital, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., STATE STREET CORP, venBio Partners LLC, PERCEPTIVE ADVISORS LLC, and MACQUARIE GROUP LTD.
This page lists
203
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
207
Q3 2023 holders
203
Holder diff
-4
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.